MODULE

Scientists link evolved, mutated gene module to syndromic autism

Medical researchers reports that newly discovered mutations in an evolved assembly of genes cause Joubert syndrome, a form of syndromic autism.

2012-2013 Psychiatric Pharmacy Review Course Course Components (ACPE Only)

The 2012-2013 CPNP Psychiatric Pharmacotherapy Review Course (ACPE Only) includes the following:

2012-2013 Psychiatric Pharmacy Review Course - ACPE Credit Only

The Psychiatric Pharmacy Review Course (Review Course) is an excellent course of study and resource for those seeking a review of psychopharmacology and current standards of care.

Read more about this session.

Course Components

The APNA Endorsed CPNP Psychiatric Pharmacotherapy Review Course includes the following:

2012-2013 APNA Endorsed CPNP Psychiatric Pharmacotherapy Review Course

In cooperation with the American Psychiatric Nurses Association (APNA), the College of Psychiatric and Neurologic Pharmacists (CPNP) is pleased to offer the APNA endorsed CPNP Psychiatric Pharmacotherapy Review Course at CPNP member rates. This course is structured to provide knowledge- based education as defined in Accreditation Council for Pharmacy Education (ACPE) guidelines. The course examinations must be submitted by December 31, 2013.

APNA members can access this Accreditation Council for Pharmacy Education (ACPE) approved distance education course at CPNP member prices. Both a for-credit and no-credit (resource only) purchase option is being provided at a cost of $320 and $150 respectively. Non members of APNA can purchase the product for $480 (for-credit) and $150 (no-credit). The 20.0 contact hours of ACPE credit are accepted for American Nurses Credentialing Center Certification Renewal. You can preview a segment of a curriculum module and speaker presentation. Read on to learn more about this great APNA offer and register now.

Registration

To access the APNA member rates, you must be logged into the web site. Log in or create a new account.

2012-2013 APNA Endorsed CPNP Psychiatric Pharmacotherapy Review CourseMembersNon-members
Psychiatric Pharmacotherapy Review Course - For Credit$320$480
Psychiatric Pharmacotherapy Review Course - No Credit$150$150

Download the printable registration form to register via mail or fax.

Accreditation (for-credit version only)

The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The 2012-2013 APNA Endorsed Psychiatric Pharmacotherapy Review Course is a knowledge-based course and will provide up to 20 contact hours (2.0 CEUs) of continuing education credit.

Statements of Credit (for-credit version only)

Registrants can obtain up to 20.0 contact hours of ACPE credit by successfully completing the CPNP Psychiatric Pharmacotherapy Review Course online examinations for each of the 14 topic areas included in the course. The course expires December 31, 2013.

ACPE Statements of Credit will be available online at cpnp.org upon successful completion of each examination for the 14 topic areas contained in the course. Successful completion is defined as achieving a score of 60% or higher on each examination. Notification of statement availability will be provided upon successful completion of the examination.

New online learning module gives children of domestic violence a voice

Over half of the residents of battered women's shelters in the United States are children, according to statistics. Now, a new, innovative online training program aims to elevate children's voices, so that service providers may better hear, understand, and respond to the children and families they serve.

NCCCN Neuropsychiatric Learning Program: Course Requirements

Access to and Completion of Modules

  1. All modules and presentations can be accessed at http://cpnp.org/ed/course/ncccn
  2. Each time you wish to access a module, you will be “purchasing” a course for free within the CPNP website.
  3. The first time you purchase a course, you will be required to complete a user profile on the CPNP system and your initial access request must be approved by Genoa which might result in a slight delay.

Ohio Zyprexa Protocol

Does anyone have any information regarding an Ohio Zyprexa Protocol? If so, can you send it to me. Does anyone have experience with it? Are there any monitoring parameters/averse events associated with it use. Thanks in advance. -----Original Message----- ...

Genoa Neuropsychiatric Pharmacy Modules: Course Requirements

Access to and Completion of Modules

  1. All modules and presentations can be accessed at http://cpnp.org/ed/course/genoa
  2. Each time you wish to access a module, you will be “purchasing” a course for free within the CPNP website.
  3. The first time you purchase a course, you will be required to complete a user profile on the CPNP system and your initial access request must be approved by Genoa which might result in a slight delay.

Genoa Neuropsychiatric Pharmacy Learning Module: Substance Abuse

At the end of this program, the participant should be able to:

  1. Identify signs and symptoms of acute intoxication, acute withdrawal, and chronic dependency associated with the use of the following drugs of abuse:
    1. Alcohol
    2. Opiates (pain medications, heroin)
    3. Nicotine
    4. Cocaine
    5. Stimulants (Methamphetamines)
    6. Inhalants
    7. Marijuana
  2. Describe the pharmacologic properties and pharmacokinetic parameters for drug therapies used in the treatment of substance use disorders.
  3. Select appropriate pharmacotherapy (agent, dose, duration of therapy) for substance use disorders based on current practice guidelines.
  4. Develop a monitoring plan that includes assessment of efficacy, and evaluation for adverse effects, drug interactions, and toxicity given a patient undergoing treatment for a substance use disorder,
  5. Compose a management strategy given a specific drug-related problem in a patient with a substance use disorder.
  6. Develop a plan to provide appropriate patient education for substance use disorders
Read more about this session.

This page may contain content contributed by CPNP members or aggregated from other online sources. This content is provided as an unmoderated service to members for civil discussion and collaboration. Any opinions, conclusions, or recommendations are those of the author. If you come across any abuse or violation of the terms of use, please report the abuse.